8/18/2019 Novartis AG v. UOI
1/16
UNIVERSITY OF PETROLEUM & ENERGY STUDIES
COLLEGE OF LEGAL STUDIES
B.B.A., LL.B (HONS.)
SEMESTER VIII
ACADEMIC YEAR: 2015-2016 SESSION: JANUARY-MAY
NOVARTIS AG v. UNION OF INDIA & OTHERS
‘Evergreening’: A !""#e $e%een Prive M'n'('#) n* Inn'vi'n
FOR
S!$+e, N-e: Ine##e,!# Pr'(er Rig"
Un*er e S!(ervi"i'n '/: A"". Pr'/. An!r* N)0
NAME: SHREYA SINGH (500022285)-R OLL NO.: R76021207
!RIYANSHU SHRI"AS#A" (50002$%71)
!RANAY !RA#A! SINGH (50002268)
1
8/18/2019 Novartis AG v. UOI
2/16
TA1LE OF CONTENTS
I. INTRODUCTION&&&&&&&&&&&&&&&&&&&&&&..$
II. CASE ANALYSIS.&&&&&&&&&&&&&&&&&&&&&&$-7
1.1 '*+ */ +/
1.2 I++/+:
1.$ A3/4*+:
1.$.1 C4*/4*4+ */ /4*
1.$.2 C4*/4*4+ */ R/+4/4*:
1. J3/4*:
1.5 H/:
III. CRITICAL ANALYSIS OF THE 2UDGMENT&&&&&&&&&&..7
IV. RESEARCH 3UESTIONS&&&&&&&&&&&&&&&&&&&&.8
1. #/ 3* */4* /3/ 4 4*/ /+ +.
2. 9/*/ S/*4 $() */ !*/4* A*, 1%70 + 4 34/ * #RI!S
1. 9/*/ */ */4* + +* * * 43;/ 4*
8/18/2019 Novartis AG v. UOI
3/16
8/18/2019 Novartis AG v. UOI
4/16
H'n>$#e 2!*ge":
A/$ A#-? Rn+nPr0" De"i?22.
C'!n"e#":
' A/4*: GS;343 4 #. R. A4=4.
' R/+4/4*+: !+
S!$+e,: Pen"
A,"=R!#e"=Or*er": +/*4 $() */ !*/4*+ A*, 1%70, +/*4 2 (1)() / * +/*4 1$$ */
A*, +/*4 2A */ A*, +/*4 25(1) */ A*, / 55 */ !*/4* R/+, 200$, A*/ 1 */
C4+***4 I4, A*/ 27 4 A*/ 6 */ #RI!S A//3/4*.
7.7 F," '/ e ,"e:
N
8/18/2019 Novartis AG v. UOI
5/16
8/18/2019 Novartis AG v. UOI
6/16
I */ *+
8/18/2019 Novartis AG v. UOI
7/16
7.8.5 C'neni'n" '/ e Re"('n*en:
#* */ ;/* =+*4/ +* */ 34 + 4/*/ 4
8/18/2019 Novartis AG v. UOI
8/16
H/
8/18/2019 Novartis AG v. UOI
9/16
4 */// */ !*/4*+ (A3/43/4*) B + 4/ ;= */ L S; 4 R= S; 4 M
*/4*= * 4 M */4*= *//, 2005, +/
8/18/2019 Novartis AG v. UOI
10/16
PRO1LEMS THAT INDIAN PATENTS COULD FACE
A+ 4/ */ / *4+ / 4* // 4 */// */ 4/ */4*+ / 4* /, /+=
4*/ /4/+ *4 */ I44 3/* / 4* * ;/ */4 ; *
8/18/2019 Novartis AG v. UOI
11/16
4+/ */ 4*/4*4 / 4+*3/4*+ */// 4 34+*/ +/ * 34/
8/18/2019 Novartis AG v. UOI
12/16
O4*4@+ (9#O) 3433 +*4+ 4*//* /*= */*4,10 ;* *+ */4* + +*
* * 43;/ 4*
8/18/2019 Novartis AG v. UOI
13/16
+;+*4/ + ;/ 4+// * ;/ */ +3/ +;+*4/, 4/++ */= / +44*= 4 /*/+ *
/ * /=. #+ 4*
8/18/2019 Novartis AG v. UOI
14/16
4*/+ + + S4/ C4 /4 4
8/18/2019 Novartis AG v. UOI
15/16
8/18/2019 Novartis AG v. UOI
16/16
1. 'ERO ALI HADER, #HE LA9 O' !A#EN#S- 9I#H A S!ECIAL 'OCUS ON
!HARMACEU#ICALS IN INDIA, (L/+N/+ 2011) (200%)
Cases referred for case analysis-
1. U* C4**+ 4 J4/= !